1. Merck & Co. Inc., Rahway, New Jersey 07065, U.S.A. E-mail: mark_mclaughlin@merck.com
2. Albany Molecular Research Inc., Syracuse Research Center, 7001 Performance Drive, North Syracuse, New York 13212, U.S.A. E-mail: silvina.garcia@albmolecular.com
3. Center for Orphan Drug Development, Department of Medicinal Chemistry, University of Minnesota, MTRF 4-210, 2001 6th Street, S.E., Minneapolis Minnesota 55455, U.S.A. E-mail: muthy003@umn.edu
4. Departamento de Quimica Inorganica, Instituto de Quimica, UFRJ, CT Bloco A, Lab. 641, Cidade Universitaria, Rio de Janeiro, RJ 21949-900, Brazil E-mail: octavio@iq.ufrj.br
5. Development Centre S.A., Parc Scientifique de Louvain-la-Neuve, Rue Granbonpre 11, B-1348 Mont-Saint-Guibert, Belgium E-mail: tilstam_ulf@lilly.com
6. Chemical R&D, Sepracor Inc., 84 Waterford Drive, Marlborough, Massachusetts 01752, U.S.A. E-mail: andrei.zlota@sepracor.com
7. Department of Chemical Engineering, University Institute of Chemical Technology, University of Mumbai, Matunga, Mumbai - 400 019, India E-mail: gdyadav@yahoo.com; gdyadav@udct.org
8. Editor